ExoMira Medicine Revenue
Biotechnology Research • 
1375 W Fulton St, Market Floor 6, United States • 1-10 Employees
$
ExoMira Medicine revenue & valuation
| Annual revenue | $256,665 |
| Revenue per employee | $86,000 |
| Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues | $821,328 |
| Total funding | No funding |
Key Contact at ExoMira Medicine
Huiping Liu
Scientific Co-Founder
Company overview
| Headquarters | 1375 W Fulton St, Market Floor 6, Chicago, Illinois 60607, US |
| Website | |
| NAICS | 541714 |
| Employees | 1-10 |
About ExoMira Medicine
ExoMira Medicine Inc. (“ExoMira”) is a Chicago-based preclinical-stage biotechnology company (a spin-off from Northwestern University) focused on developing innovative cancer immunotherapies.
Employees by Management Level
Total employees: 1-10
Seniority
Employees
Founder/Owner
Employees by Department
ExoMira Medicine has 1 employees across 1 departments.
Departments
Number of employees
Funding Data
ExoMira Medicine has never raised funding before.
Australia
India
Frequently asked questions
ExoMira Medicine is located in 1375 W Fulton St, Market Floor 6, US.
ExoMira Medicine generates an estimated annual revenue of $256,665. This revenue figure reflects the company's market position and business performance in its industry.
ExoMira Medicine has an estimated valuation of $821,328. This valuation is calculated based on industry-standard revenue multiples and reflects the company's growth potential and market positioning.
ExoMira Medicine has approximately 1-10 employees. The company continues to grow its workforce to support its business operations and expansion.
4.8
40,000 users
